Conditions: Hypertension Hypercholesterolemia Angina Pectoris
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 159
Healthy volunteers: no

Brief summary:
The primary objective is to investigate the safety of Caduet (2.5 mg/5 mg, 2.5 mg/10 mg, 5 mg/5 mg or 5 mg/10 mg as dose of Amlodipine/Atorvastatin) during 52 weeks treatment period in Japanese patients with both of hypertension and hypercholesterolemia, or with both angina pectoris and hypercholesterolemia.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Caduet
Intervention descriptions: intervention 1: One Caduet tablet will be administered once daily after breakfast, in principle, for 52 weeks

Protocol document: